These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 30885933)
61. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract. Kiedrowski MR; Bomberger JM Front Immunol; 2018; 9():3067. PubMed ID: 30619379 [TBL] [Abstract][Full Text] [Related]
62. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960 [TBL] [Abstract][Full Text] [Related]
63. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. Winstanley C; Fothergill JL FEMS Microbiol Lett; 2009 Jan; 290(1):1-9. PubMed ID: 19016870 [TBL] [Abstract][Full Text] [Related]
64. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study. Millar BC; Rendall JC; Downey DG; Moore JE J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786 [TBL] [Abstract][Full Text] [Related]
65. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988 [TBL] [Abstract][Full Text] [Related]
66. RhlR-Regulated Acyl-Homoserine Lactone Quorum Sensing in a Cystic Fibrosis Isolate of Pseudomonas aeruginosa. Cruz RL; Asfahl KL; Van den Bossche S; Coenye T; Crabbé A; Dandekar AA mBio; 2020 Apr; 11(2):. PubMed ID: 32265330 [TBL] [Abstract][Full Text] [Related]
67. Pseudomonas aeruginosa and the airways disease of cystic fibrosis. Hata JS; Fick RB Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384 [TBL] [Abstract][Full Text] [Related]
69. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related]
70. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614 [TBL] [Abstract][Full Text] [Related]
71. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426 [TBL] [Abstract][Full Text] [Related]
72. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Hogardt M; Heesemann J Int J Med Microbiol; 2010 Dec; 300(8):557-62. PubMed ID: 20943439 [TBL] [Abstract][Full Text] [Related]
73. Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture. Li K; Gifford AH; Hampton TH; O'Toole GA J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31685535 [TBL] [Abstract][Full Text] [Related]
74. Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress. Lopes SP; Azevedo NF; Pereira MO Int J Med Microbiol; 2017 Dec; 307(8):460-470. PubMed ID: 29033313 [TBL] [Abstract][Full Text] [Related]
75. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance. Sousa AM; Monteiro R; Pereira MO Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031 [TBL] [Abstract][Full Text] [Related]
76. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381 [TBL] [Abstract][Full Text] [Related]
77. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153 [TBL] [Abstract][Full Text] [Related]
78. Same Game, Different Players: Emerging Pathogens of the CF Lung. Gannon AD; Darch SE mBio; 2021 Jan; 12(1):. PubMed ID: 33436426 [TBL] [Abstract][Full Text] [Related]